introduction Human immunodeficiency virus (HIV)-infected individuals are at increased risk for all forms of extrapulmonary tuberculosis (TB), including tuberculous meningitis (TBM). This study aimed to investigate the frequency of HIV in patients with TBM.
Introduction
Tuberculosis (TB) and human immunodeficiency virus (HIV) are infectious causes of death globally. In 2016, 10.4 million people contracted TB, and 1.7 million died from it [1] . TB meningitis (TBM) is the most severe form of TB, with significant morbidity and mortality [2, 3] . Approximately 30% of patients with TBM die despite TB treatment [4] . The clinical features of TBM are similar to those other meningoencephalitides, making diagnosis difficult [3] . Consequently, delay in diagnosis and start of treatment have a negative impact on patient outcome [3] . The human immunodeficiency virus (HIV) epidemic has complicated all aspects of TBM management. Infection is more likely to progress to TBM when patients are coinfected with HIV [5] . The case fatality rate for TBM in adults is higher among HIV-infected patients than among uninfected patients [6, 7] . Although the magnitude of HIV in TBM cases is well described, the frequency of HIV in such high-risk patients has not been reported. So far, several hospital-based studies have reported the frequency of HIV in TBM cases; however, there are increasing discrepancies between the results. Thus, this study was designed to determine the frequency of HIV in patients with TBM by systematic review and meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement [8] .
Methods

Search strategies
PubMed, Embase, Web of Science and Cochrane Library were searched for articles published between January 1985 and March 2018. Search terms were 'tuberculous meningitis', 'TBM', 'acquired immunodeficiency syndrome', 'AIDS', 'HIV' and 'human immunodeficiency virus'. Titles, abstracts and full texts of retrieved articles were screened and assessed for eligibility independently and in duplicate by two investigators. Reference lists of selected articles were searched to identify further relevant studies.
Eligibility
Inclusion criteria. Studies were included if they met all of the following criteria: (i) evaluating TBM; (ii) presenting the frequency of HIV in TBM cases; and (iii) reporting standard laboratory-confirmed TBM. We used the case definition by Marais et al. [9] for TBM. Briefly, for definite TBM, patients should fulfil clinical entry criteria plus one or more of the following: acid-fast bacilli seen in the CSF; Mycobacterium tuberculosis cultured from CSF; or CSF-positive commercial nucleic acid amplification test. Patients without microbiological confirmation were classified as probable, possible or not TBM, depending on their total diagnostic score.
Exclusion criteria. Studies were excluded if they focused only on TBM or HIV, did not report confirmed TBM or did not report the frequency of HIV in TBM.
Data extraction and data collection
Data were extracted by two reviewers independently and inconsistencies checked by a third reviewer. We extracted the following data from each article: name of the first author, publication date, country, number of suspected meningitis cases, number of confirmed TBM cases, and number of HIV+TBM cases.
Quality assessment
Quality assessment of the studies was performed according to the Critical Appraisal Checklist recommended by the Joanna Briggs Institute [10] . Studies with score >6 were included in the final analysis.
Meta-analysis
Analyses were performed using random-effects weights. To estimate a pooled effect, we utilised the 'metaprop' command. We used 'ftt cimethod' (score) or FreemanTukey transformation procedures for collecting binomial data. The between-study heterogeneity was assessed using Cochran's Q, the I 2 statistic and Galbraith graph. To check for publication bias, we generated funnel plots and used Egger's and Begg's tests (P < 0.05 was considered indicative of statistically significant publication bias, funnel plot asymmetry also suggest bias in the metaanalysis). All the analyses were conducted using Stata 14.0 (StataCorp, College Station, Texas, USA).
Results
A total of 1099 articles were found in the initial search, of which 485 records were screened by title and abstract, and 20 studies were included in the final analysis [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ( Figure 1 ). Table 1 summarises the main characteristics of the included studies. The target population in 18 of 20 studies was adult patients with TBM; in the two remaining studies, it was children. In all included studies, TBM was investigated by standard criteria as described previously [9] . All included studies reported the frequency of HIV among patients with TBM. A total of 1197 patients with TBM were included in the meta-analysis. These reports came from 12 countries and were written between 1998 and 2018.
Risk of bias assessment
Based on the quality assessment of the included studies, all studies were identified as having a low risk of bias.
HIV infection in patients with TBM
The pooled frequency of HIV among adult patients with TBM was 38.0% (95% CI: 21.0-57.0; I 2 = 97%) (Figure 2) . Likewise, 6.0% (95% CI: 1.0-13.0; I 2 = 0.0%) of children (under the age of 15 years) with TBM had HIV infection. As presented in the Galbraith plot in Figure 3 , the studies outside the range between À2 and 2 were seen as the outliers and the major source of heterogeneity. On visual inspection, the funnel plot appears asymmetric (Figure 4) . However, as per Begg's (P = 0.1) and Egger's (tests) (P = 0.7), there was no evidence of asymmetry. 
HIV infection in patients with other bacterial meningitis
The pooled frequency of HIV among patients with bacterial meningitis other than TBM was 36.0% (95% CI: 19.0-53.0; I 2 = 100%) ( Figure S1 ). The funnel plot shows some evidence of publication bias (P < 0.05 for Begg's rank correlation analysis and Egger's weighted regression analysis) ( Figure S2 ).
Discussion
TB and HIV co-infection is the leading cause of mortality among patients with TB and people living with HIV/AIDS. The prevalence and incidence of both TB and HIV have globally increased in recent years [1] . TBM is the most severe form of TB and carries a high morbidity and mortality [31] . Infection with HIV is among the powerful known risk factors predisposing for progression to active TBM [2] . According to our study, 38.0% of TBM was HIV-associated TBM. The relatively high frequency of HIV in TBM may have several negative effects on patient's management. For example, in terms of laboratory features, the diagnosis of TBM can be masked by atypical CSF findings. Previous studies indicated a lower CSF leucocyte count and a lower protein level in HIV-infected patients [32] [33] [34] . Typically, in patients with TBM, there is lymphocytic pleocytosis, with an elevated protein and low glucose levels [35, 36] . HIV could also alter the clinical presentation of TBM. In TBM patients with HIV, basal meningeal enhancement and hydrocephalus on CT might be less common and there could be more bacilli in the meninges than in those who are HIV-uninfected [36, 37] . In terms of treatment and outcome, a previous study reported more treatment failures in HIVinfected patients with TBM than in HIV-uninfected patients, which suggests that HIV infection may influence responses to treatment and the likelihood of having a relapse [32] . The case fatality rate is significantly higher in HIV-infected than uninfected adults [37, 38] . Resistance to TB drugs is among the most important factors that may have contributed to the high case fatality rate in HIV-infected patients with TBM. A higher proportion of M. tuberculosis isolates from HIVinfected patients was resistant to more than one firstline TB drug [2, 37] . Also, the optimal time to initiate antiretroviral therapy (ART) in patients with HIV and TB co-infection remains controversial. Early initiation of ART with TB treatment may be associated with drug toxicities, while delayed initiation may result in HIV disease progression and death [39] .
The current study has some limitations. First, it cannot represent the global prevalence of HIV in TBM because the magnitude of the issue is not yet investigated in many countries. Second, heterogeneity exists among the included studies. Although the random-effects model allows for heterogeneity, controversy remains about combining study estimates in its presence. Third, as with any systematic review, limitations associated with potential publication bias should be considered. Finally, the mortality rate, treatment failures and CSF parameters in TBM patients with and without HIV infection could not be analysed because of the limited information obtained from the studied articles.
In conclusion, our systematic review and meta-analysis indicate a relatively high frequency of HIV in patients Figure 3 Galbraith plot of the frequency of HIV among patients with TBM (The study outside the range between À2 and 2 was seen as the outlier and the major source of heterogeneity). with TBM. Establishment of diagnostic criteria and effective treatment strategies for TBM/HIV co-infection are recommended for better management of TBM/HIV coinfection.
